Hansson J - Search Results

1

NRAS and BRAF mutations in melanoma tumours in relation to clinical characteristics: a study based on mutation screening by pyrosequencing.

Edlundh-Rose E, Egyházi S, Omholt K, Månsson-Brahme E, Platz A, Hansson J, Lundeberg J. Edlundh-Rose E, et al. Among authors: hansson j. Melanoma Res. 2006 Dec;16(6):471-8. doi: 10.1097/01.cmr.0000232300.22032.86. Melanoma Res. 2006. PMID: 17119447

2

Pyrosequencing as an alternative to single-strand conformation polymorphism analysis for detection of N-ras mutations in human melanoma metastases.

Sivertsson A, Platz A, Hansson J, Lundeberg J. Sivertsson A, et al. Among authors: hansson j. Clin Chem. 2002 Dec;48(12):2164-70. Clin Chem. 2002. PMID: 12446472

3

NRAS and BRAF mutations arise early during melanoma pathogenesis and are preserved throughout tumor progression.

Omholt K, Platz A, Kanter L, Ringborg U, Hansson J. Omholt K, et al. Among authors: hansson j. Clin Cancer Res. 2003 Dec 15;9(17):6483-8. Clin Cancer Res. 2003. PMID: 14695152

4

Mutations of PIK3CA are rare in cutaneous melanoma.

Omholt K, Kröckel D, Ringborg U, Hansson J. Omholt K, et al. Among authors: hansson j. Melanoma Res. 2006 Apr;16(2):197-200. doi: 10.1097/01.cmr.0000200488.77970.e3. Melanoma Res. 2006. PMID: 16567976

5

No evidence of RALGDS mutations in cutaneous melanoma.

Omholt K, Hansson J. Omholt K, et al. Among authors: hansson j. Melanoma Res. 2007 Dec;17(6):410-2. doi: 10.1097/CMR.0b013e3282ef4178. Melanoma Res. 2007. PMID: 17992125 No abstract available.

6

Human cutaneous melanoma; a review of NRAS and BRAF mutation frequencies in relation to histogenetic subclass and body site.

Platz A, Egyhazi S, Ringborg U, Hansson J. Platz A, et al. Among authors: hansson j. Mol Oncol. 2008 Apr;1(4):395-405. doi: 10.1016/j.molonc.2007.12.003. Epub 2007 Dec 28. Mol Oncol. 2008. PMID: 19383313 Free PMC article.

7

Screening of N-ras codon 61 mutations in paired primary and metastatic cutaneous melanomas: mutations occur early and persist throughout tumor progression.

Omholt K, Karsberg S, Platz A, Kanter L, Ringborg U, Hansson J. Omholt K, et al. Among authors: hansson j. Clin Cancer Res. 2002 Nov;8(11):3468-74. Clin Cancer Res. 2002. PMID: 12429636

8

Frequency of UV-inducible NRAS mutations in melanomas of patients with germline CDKN2A mutations.

Eskandarpour M, Hashemi J, Kanter L, Ringborg U, Platz A, Hansson J. Eskandarpour M, et al. Among authors: hansson j. J Natl Cancer Inst. 2003 Jun 4;95(11):790-8. doi: 10.1093/jnci/95.11.790. J Natl Cancer Inst. 2003. PMID: 12783933

9

Germline CDKN2A mutations are rare in child and adolescent cutaneous melanoma.

Berg P, Wennberg AM, Tuominen R, Sander B, Rozell BL, Platz A, Hansson J. Berg P, et al. Among authors: hansson j. Melanoma Res. 2004 Aug;14(4):251-5. doi: 10.1097/01.cmr.0000131014.79262.bf. Melanoma Res. 2004. PMID: 15305154

10

Biallelic deletions in INK4 in cutaneous melanoma are common and associated with decreased survival.

Grafström E, Egyházi S, Ringborg U, Hansson J, Platz A. Grafström E, et al. Among authors: hansson j. Clin Cancer Res. 2005 Apr 15;11(8):2991-7. doi: 10.1158/1078-0432.CCR-04-1731. Clin Cancer Res. 2005. PMID: 15837753

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

474 results

Search Page

Filters